A House Energy and Commerce subcommittee hearing highlighted the emerging conflict between drug policies and scientific ...
A decision to reclassify marijuana as a Schedule III drug would completely change how the industry pays for it, how we think of weed, and what we can learn about it. The U.S Drug Enforcement ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results